dipyridamole has been researched along with Extramembranous Glomerulopathy in 6 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h protein excretion; the latter amounted to 54% with dipyridamole alone and 56% with dipyridamole plus aspirin (NS)." | 1.28 | Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis. ( Cámara, S; De La Cruz, JP; Frutos, MA; Sánchez De La Cuesta, F, 1992) |
| "Sixty-five patients with primary membranous nephropathy were examined in order to assess the effects of long-term treatment with corticosteroid." | 1.28 | Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid. ( Funabiki, K; Koide, H; Shirato, I; Tomino, Y; Yoshida, M, 1992) |
| "Between 1973 and 1986, 109 patients with membranous nephropathy have been evaluated with respect to clinical presentation, pathological features and factors determining prognosis." | 1.27 | The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy. ( Aarons, I; Clarkson, AR; Shearman, JD; Smith, PS; Woodroffe, AJ; Yin, ZG, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horino, T | 1 |
| Kuriyama, S | 1 |
| Tomonari, H | 1 |
| Numata, M | 1 |
| Hayashi, F | 1 |
| Nagata, H | 1 |
| Hikita, M | 1 |
| Utsunomiya, Y | 1 |
| Kawamura, T | 1 |
| Hosoya, T | 1 |
| Goto, T | 1 |
| Komatsu, M | 1 |
| Fujii, T | 1 |
| Ohshima, S | 1 |
| Nakane, K | 1 |
| Yoneyama, K | 1 |
| Shibuya, T | 1 |
| Meng, XW | 1 |
| Masamune, O | 1 |
| Imai, H | 1 |
| De La Cruz, JP | 1 |
| Cámara, S | 1 |
| Frutos, MA | 1 |
| Sánchez De La Cuesta, F | 1 |
| Funabiki, K | 1 |
| Tomino, Y | 1 |
| Shirato, I | 1 |
| Yoshida, M | 1 |
| Koide, H | 1 |
| Murphy, BF | 1 |
| McDonald, I | 1 |
| Fairley, KF | 1 |
| Kincaid-Smith, PS | 1 |
| Shearman, JD | 1 |
| Yin, ZG | 1 |
| Aarons, I | 1 |
| Smith, PS | 1 |
| Woodroffe, AJ | 1 |
| Clarkson, AR | 1 |
1 trial available for dipyridamole and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
Topics: Cyclophosphamide; Dipyridamole; Drug Administration Schedule; Drug Therapy, Combination; Female; Glo | 1992 |
5 other studies available for dipyridamole and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
[Renal damage in a chronic active hepatitis C patient receiving interferon-alpha therapy].
Topics: Aged; Anticoagulants; Antiviral Agents; Dipyridamole; Glomerulonephritis, Membranous; Heparin; Hepat | 1998 |
Primary biliary cirrhosis associated with membranous glomerulonephritis.
Topics: Adult; Azathioprine; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Dipyridamole; Dru | 1999 |
Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hum | 1992 |
Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Dipyridamole; Drug Therapy, Combin | 1992 |
The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
Topics: Adolescent; Adult; Aged; Biopsy; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Female; | 1988 |